Skip to content

Author

H. Kang

We have 1 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Engineering the blood: Lipid nanoparticle platforms for ex vivo immune and hematopoietic cell therapies.

This review aims to provide actionable guidance to bench-side cell engineering to broad clinical applications by comprehensively discussing recent advancements in LNP formulation and next-generation RNA payload engineering.

Yongjoo Byeon, Nuoya Peng, Eun Bee Oh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.